BEGIN:VCALENDAR
VERSION:2.0
PRODID:ADNA Events System
X-WR-TIMEZONE:America/Toronto
BEGIN:VTIMEZONE
TZID:America/Toronto
X-LIC-LOCATION:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0500
DTSTART:19810329T020000
RRULE:FREQ=YEARLY;INTERVAL=1;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:69e2552c05600
DTSTART;TZID=America/Toronto:20260121T200000
SEQUENCE:0
TRANSP:OPAQUE
DTEND;TZID=America/Toronto:20260121T213000
URL:https://secure.cas.ca/events/index.html/event-info/details/id/60
SUMMARY:Intraoperative management for major liver resection: An update
CLASS:PUBLIC
DESCRIPTION:Patients coming for liver resection are increasingly comorbid a
 nd having increasingly aggressive resections. The rate of mortality has de
 creased substantially\; however\, the rate of postoperative morbidity cont
 inues to be high. Perioperative blood conservation techniques are a critic
 al contributor to outcomes for patients having major liver resection. Rece
 iving a blood transfusion during the surgical hospitalization is associate
 d with poor outcomes. Recent large-scale randomized controlled trials have
  emerged regarding the use of intraoperative hypovolemic phlebotomy and an
 tifibrinolytic medications (tranexamic acid) providing key insight to mana
 ging these patients. This session will aim to discuss an evidence-based ap
 proach to intraoperative care for patients having major liver resection an
 d to delve into hypovolemic phlebotomy in detail.\n\nhttps://secure.cas.ca
 /events/index.html/event-info/details/id/60
X-ALT-DESC;FMTTYPE=text/html:<p>Patients coming for liver resection are inc
 reasingly comorbid and having increasingly aggressive resections. The rate
  of mortality has decreased substantially\; however\, the rate of postoper
 ative morbidity continues to be high. Perioperative blood conservation tec
 hniques are a critical contributor to outcomes for patients having major l
 iver resection. Receiving a blood transfusion during the surgical hospital
 ization is associated with poor outcomes. Recent large-scale randomized co
 ntrolled trials have emerged regarding the use of intraoperative hypovolem
 ic phlebotomy and antifibrinolytic medications (tranexamic acid) providing
  key insight to managing these patients. This session will aim to discuss 
 an evidence-based approach to intraoperative care for patients having majo
 r liver resection and to delve into hypovolemic phlebotomy in detail.&nbsp
 \;&nbsp\; &nbsp\;</p>\n\n<p>After attending the webinar\, participants wil
 l be able to:</p>\n\n<p>1. Identify evidence-based intraoperative manageme
 nt strategies for major liver resection surgeries.</p>\n\n<p>2. Consider i
 mplementing intraoperative hypovolemic phlebotomy for major liver resectio
 n surgeries.</p>\n\n<p>3. Articulate evidence-based perioperative blood co
 nservation strategies for liver resection surgeries.</p>\n\n<p><strong><em
 >Note&nbsp\;- Your CAS Membership must be in good standing for the event d
 ate in order to access the member discount.&nbsp\;<a href=\"https://secure
 .cas.ca/access/login.html?redirect=https%3A%2F%2Fsecure.cas.ca%2Fmembershi
 p%2Frenew.html\" target=\"_blank\">Click here to renew</a>.&nbsp\;&nbsp\;<
 /em></strong></p>\n
DTSTAMP:20260417T114340Z
END:VEVENT
END:VCALENDAR